Buy or sell AbCellera Biologics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

AbCellera Biologics Stock

Antibody therapeutics

About AbCellera Biologics Stock

AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.

Funding History

September 2013$0
August 2014$0
January 2017$0
April 2017$818K
September 2018$10.0M
March 2019$4.8M



Kevin Heyries

Co-Founder & Director

Véronique Lecault

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from AbCellera Biologics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: